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Thrombospondin 2 (TSP2)-null mice, generated by
targeted disruption of the Thbs2 gene, display a
complex phenotype that is characterized, in part, by
a variety of connective tissue abnormalities and
increased vascular density in skin and subcutaneous
tissues. In this paper we summarize the evidence that
TSP2 functions as a matricellular protein to in¯uence
cell function by modulating cell±matrix interactions,
rather than acting as an integral component of the
matrix. Thus, the structurally abnormal collagen
®brils detected in skin appear to be the consequence
of the defective adhesion demonstrated by dermal
®broblasts in culture that, in turn, result from
increased matrix metalloproteinase 2 (MMP2, gela-
tinase A) production by these cells. Corroborating
evidence for such a mode of action comes from
transmission electron microscopic images of develop-
ing ¯exor muscle tendons that show distinct abnorm-
alities in ®broblast±collagen ®bril interactions in
TSP2-null tissue. The increased vascular density seen
in skin of TSP2-null mice can be reproduced in a
number of models of injury, including subcutaneous
implantation of polyvinyl alcohol sponges and silicone
rubber discs, and excisional skin wounds. Experiments
are proposed to distinguish between a primarily
endothelial cell versus an extracellular matrix origin for
the increased angiogenesis in TSP2-null mice. Key
words: cell adhesion/cell±matrix interactions/extracellular
matrix/matricellular protein/matrix metalloproteinase.
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T
hrombospondin (TSP) 2 is a member of a group of
functionally related, extracellular matrix (ECM)
proteins that also includes TSP1, osteopontin,
tenascin C, SPARC, and probably other proteins.
These proteins do not subserve a primary structural
role, in the sense that most collagens, elastins, and laminins are
structural proteins. Matricellular proteins, however, interact with
structural proteins and heparan sulfate proteoglycans, as well as with
cytokines, proteases, and cell-surface receptors to function
contextually as adaptors and modulators of cell±matrix interactions
(Bornstein, 1995). The complex nature of their function derives
from their ability to interact with multiple cell-surface receptors, to
bind and activate cytokines, to inhibit the effects of growth factors,
and to serve as competitive inhibitors of proteases. The contextual
nature of this function thus re¯ects the composition of the matrix,
the availability of cytokines and proteases, and the expression of
integrins and other receptors in a given cellular environment
(Bornstein, 1995). An additional level of complexity results from
the ability of some matricellular proteins to undergo limited
proteolytic cleavage to reveal cryptic functions, e.g., SPARC (Sage,
1997) and osteopontin (Smith et al, 1996). Whereas we believe that
the conceptual distinctions between structural and matricellular
proteins are useful, they should not be considered to be absolute.
Thus, it is clear that structural proteins such as collagens and
laminins can in¯uence cell function by interacting with integrin
receptors and activating cell-signaling pathways. On the other
hand, in some circumstances, matricellular proteins may affect the
structure of the matrix directly, e.g., the ability of osteopontin to
inhibit calci®cation in smooth muscle cell cultures (Wada et al,
1999), and possibly in soft tissues in vivo.
In view of the structural similarity between TSP2 and TSP1
(Bornstein and Sage, 1994), it is likely that many of the
macromolecular interactions that have been established for TSP1
(Frazier, 1991; Bornstein, 1995) also apply to TSP2. Indeed, TSP2,
like TSP1, has been shown to bind heparan sulfate proteoglycans,
low-density lipoprotein-related receptor protein, and the integrin
avb3 (Chen et al, 1994, 1996). TSP2 has also been shown to inhibit
the angiogenic activity of bFGF in a corneal assay (Volpert et al,
1995), and mitogenesis and formation of focal adhesions in bovine
aortic endothelial cells (Murphy-Ullrich et al, 1993; Panetti et al,
1997). In the main, however, the functional properties of TSP2 in
vivo have not been elucidated.
In an attempt to gain a better understanding of the biologic role
of this matricellular protein, TSP2-null mice were generated by
disruption of the Thbs2 gene in murine embryonic stem (ES) cells,
and the mutant ES cells were used to generate TSP2 knockout
mice by use of now well-established techniques (Koller and
Smithies, 1992). Mice that lack TSP2 develop a complex
phenotype characterized by abnormalities in connective tissues,
changes in ®broblast adhesion, increased endosteal bone growth, an
increase in vascular density, and a bleeding diathesis (Kyriakides et al,
1998a). In this paper we describe the changes in collagen ®bril
structure and the increased angiogenesis that have been found in
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TSP2 knockout mice, and discuss the possible mechanisms that
might be responsible for these changes. Our ®ndings support the
concept that the functions of TSP2 do not result from its physical
presence in the ECM, but rather derive from the modulation of
cell±matrix interactions and cell function by the protein.
RESULTS AND DISCUSSION
Collagen ®brillogenesis Previously published ®ndings indicated
that the skin of TSP2-null mice was fragile and had reduced tensile
strength, and histologic analysis of skin showed that collagen ®bers
were disorganized and lacked the normal, predominantly parallel
orientation to the epidermal surface (Kyriakides et al, 1998a). In
addition, electron microscopic examination revealed the presence of
abnormally large collagen ®brils with irregular contours in tissues
from mutant mice (Kyriakides et al, 1998a). These ®ndings could
result from a role of TSP2 as a collagen ®bril-associated protein,
because similar ®ndings had been reported in mice with de®ciencies
of the ®bril-associated proteins type V collagen, decorin, and
®bromodulin (Andrikopoulos et al, 1995; Danielson et al, 1997;
Svensson et al, 1999). The presence of TSP2 as an integral component
of collagen ®brils, however, could not be documented by light
microscopic immunohistochemistry in either the developing or the
adult mouse (Kyriakides et al, 1998b).
If TSP2 does not affect collagen ®brillogenesis by its physical
presence in ®brils, as suggested by the matricellular hypothesis, the
protein could still do so by in¯uencing ®broblast function and cell±
matrix interactions, or the function of another cell that secondarily
affects ®broblast function. Alternatively, TSP2 could serve as a
nucleation site for initial assembly of ®brils, either at the cell surface
or by interaction with procollagen during the secretory process.
It has been shown by transmission electron microscopy that
®broblasts compartmentalize the pericellular space by extension
of long cellular processes. Nascent collagen ®brils subsequently
assemble in the resulting extracellular compartments, in close
association with the cell surface (Birk and Trelstad, 1986; Birk
and Linsenmayer 1994). It seems likely that cells interact with
the ®bril during this process and that such interactions are
compromised in TSP2-null mice. Indirect evidence for a mode
of action at the level of cell±matrix interactions was obtained by
examination of tendons from early postnatal control and TSP2-
null mice. In these experiments, the hind limb ¯exor tendons
from postnatal day 4 and day 8 TSP2-null and wild-type (WT)
littermates were cut in cross section and examined by
transmission electron microscopy. This analysis of matrix
development demonstrated that ®bril-forming channels, ®ber-
forming compartments, and larger ®broblast-de®ned compart-
ments were well de®ned at postnatal day 4 (Fig 1). The
structure of the ®bril-forming channels was unaltered in TSP2-
null mice relative to WT controls; however, the ®ber-forming
compartments and larger, ®broblast-de®ned compartments were
signi®cantly less organized in the TSP2-null mice. The long
Figure 1.Compartmentalization of the devel-
oping tendon matrix. Hind limb ¯exor tendons
from postnatal day 4 littermates were cut in cross-
section and examined by transmission electron
microscopy. Wild-type (A) and TSP2-null (B)
tendons show a compartmentalization of the ex-
tracellular space. Both show extracytoplasmic
channels (arrowheads) where ®brils assemble and a
second compartment where ®brils coalesce into
®bril bundles/small ®bers (labeled B). As develop-
ment proceeds the cytoplasmic processes de®ning
these compartments retract (curved arrows) and lar-
ger ®bers characteristic of the mature tendon
form. The latter two levels of compartmentaliza-
tion are disrupted in tendons from TSP2-null
mice. Thus, the cytoplasmic processes de®ning de-
veloping ®bers are less regular in TSP2-null ten-
don. The orientation of the ®bers and ®bril
packing within the ®bers are also less regular in
mutant tendons. Abnormal ®broblasts that are ap-
parently apoptotic (*) are often seen in ®elds of
normal-appearing tendon ®broblasts in TSP-2 null
tendons. Such cells are rarely seen in control tis-
sue. N, nucleus. Section stained with uranyl acet-
ate and phosphotungstic acid. Scale bar: 2.5 mm.
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cytoplasmic processes that de®ne these compartments were less
regular in orientation and less extended in the TSP2-null mice
(Fig 1). This disruption of cellular compartmentalization of the
extracellular matrix was associated with ®ber disorganization in
the mutant mice, relative to WT controls. Fibers had regular
orientation in the normal mice, but this was partially lost in the
mutant. Collagen ®bril packing, within the ®bers, was less
regular in the TSP2-null tendon, and the ®bers from mutant
mice had more spaces than in the wild type (Fig 2). Even at
these early stages of development, there was a tendency toward
larger diameter ®brils in the TSP2-null tissue, but this was not
as dramatic as seen in adult tissues (Kyriakides et al, 1998a).
During these early developmental periods, ®broblasts and their
associated matrix normally begin the processes involved in tendon
fascicle development. These cell±cell and cell±matrix interactions
are apparently abnormal in the TSP2-null tendons because fascicle
formation was disrupted relative to the WT controls (Fig 2). In
addition to these changes, ®broblasts that appear histologically to be
apoptotic were frequently observed in ®elds of normal ®broblasts in
the TSP2-null mice (Figs 1, 2). Such cells were virtually absent
from normal tendons.
Cell adhesion Additional, more direct evidence for a cellular
etiology for the abnormal collagen ®bril structure in TSP2-null
mice was obtained by examining the functions of dermal ®broblasts
in culture. TSP2-null dermal ®broblasts were found to aggregate
more readily in monolayer cultures and were more sensitive to
trypsinization from tissue culture plastic than were control cells
(Kyriakides et al, 1998a). These ®ndings suggested that TSP2-null
cells have a defect in cell±matrix interactions, and ran counter to
expectations, because TSP2 had been shown to destabilize focal
adhesions in endothelial cells in vitro (Murphy-Ullrich et al, 1993).
We have now characterized the ®broblast adhesive defect in greater
detail. In this study, cell attachment assays were performed in the
absence of serum and the behavior of dermal ®broblasts, derived
from both WT and TSP2-null mice, was compared. On tissue
culture plastic, attachment of TSP2-null cells was signi®cantly
decreased compared with normal cells. Coating of the surface with
®bronectin increased the attachment of both WT and TSP2-null
cells, but did not completely correct the adhesive defect of TSP2-
null cells (Fig 3A). Similar results were observed with vitronectin
and type I collagen (data not shown), as well as with TSP2 itself
(Fig 3B).
The failure to correct the attachment defect of TSP2-null
®broblasts in culture by addition of TSP2 to the substratum raised
the possibility that this defect was a secondary consequence of the
TSP2-de®cient state. Stable transfections of dermal ®broblasts with
TSP2 cDNA were attempted, but were unsuccessful because
selected cells soon became senescent, or occasionally became
transformed. We therefore generated TSP2-de®cient mice that
carried the conditionally immortalizing SV40 large T antigen,
H-2kb-tsA58, as a transgene by crossing TSP2-null mice with
Figure 2. Fibroblast interactions involved in
tendon fascicle and ®ber development. Trans-
mission electron micrographs of cross-sections of
hind limb ¯exor tendons from postnatal day 8 lit-
termates. Wild-type (A) and TSP2-null (B) ten-
dons. As tendon development proceeds, TSP-2
null mice continue to show disorganization of ®-
broblasts and ®bers. The cytoplasmic processes de-
®ning compartments are less prominent and more
disorganized in mutant tendons. The ®bers and
packing of ®brils within the ®bers also are less or-
ganized in mutant tendons relative to WT con-
trols. Abnormal ®broblasts that are apparently
apoptotic (*) are often seen in ®elds of normal-ap-
pearing tendon ®broblasts in TSP-2 null tendons,
but are virtually absent from control tissue. B, ®-
bers or ®bril-bundles; curved arrows, cytoplasmic
processes de®ning the ®ber-forming compart-
ments; N, nucleus; G, Golgi. Stained with uranyl
acetate and phosphotungstic acid. Scale bar:
2.5 mm.
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transgenic Immortomice (Jat et al, 1991). Dermal ®broblasts derived
from these mice could be grown inde®nitely at the permissive
temperature of 33°C, but acquired normal characteristics when
grown at 37°C for a few days. The attachment of non-
transfected, immortalized TSP2-null ®broblasts resembled that of
nonimmortalized TSP2-null cells and was reduced relative to WT
cells (data not shown). Thus, at least as regards attachment, we can
assume that immortalization with SV40 large T antigen, followed
by culture of cells under nonpermissive conditions, does not change
the properties of these cells. Cell attachment assays showed that
transfection with TSP2 cDNA rescued the adhesive defect of
immortalized TSP2-null ®broblasts, whereas the attachment of cells
transfected with antisense TSP2 cDNA was comparable with that
of nontransfected TSP2-null ®broblasts (Fig 3C).
During the course of attachment assays, and even after replating
TSP2-null ®broblasts, it was noted that these cells spread far more
slowly than normal cells. When dermal ®broblasts were plated on
chamber slides in the presence of serum and stained with
phalloidin, WT cells appeared well spread with clearly de®ned
actin-containing stress ®bers, whereas TSP2-null cells showed little
spreading and a peripheral deposition of actin (Fig 4). Thus, the
morphology of the actin cytoskeleton in TSP2-null ®broblasts is
abnormal, a ®nding that is indicative of compromised cell±matrix
interactions and establishes that these cells are defective in cell
spreading as well as in attachment. The morphology of the actin
cytoskeleton reverted to normal in TSP2-null cells that had been
stably transfected with sense TSP2 cDNA (data not shown), a
®nding that supports our conclusion that the spreading defect in
TSP2-null cells results from a lack of TSP2.
Recent studies have shown that TSP2-null ®broblasts in culture
produce twice as much matrix metalloproteinase 2 (MMP2)
protein as do normal ®broblasts (Fig 5; Yang et al, 2000).
Importantly, the increased MMP2 observed in the conditioned
media of TSP2-null cells was reduced to a level approaching that in
conditioned media from WT cells by transfection with TSP2
cDNA. Quanti®cation of the gelatinolytic activity in conditioned
media of TSP2-transfected TSP2-null cells indicated that 76% of
the difference between the activities of WT and TSP2-null cells
had been restored by replacement of the TSP2 cDNA gene.
Furthermore, the attachment of TSP2-transfected cells was restored
to normal levels (Yang et al, 2000). These ®ndings suggest that
increased metalloproteinase activity contributes to the attachment
defect in TSP2-null cells and, possibly, to the abnormal collagen
®brillogenesis in TSP2-null mice. TSP2-null ®broblasts were also
found, by FACS analysis, to display decreased levels of a1 and
increased levels of b1 integrins on their cell surfaces (Yang et al,
unpublished observations), but the functional signi®cance of these
changes is not known because at least the level of a1 integrin did
not revert to normal in TSP2-transfected cells.
Angiogenesis TSP2, like TSP1, was shown to be antiangiogenic
in cell migration and rodent corneal assays (Volpert et al, 1995).
This function was con®rmed in TSP2-de®cient mice in which it
Figure 3. Fibroblast attachment assays. (A) Comparison of attachment of WT and TSP2-null skin ®broblasts. Skin ®broblasts were suspended in serum-
free medium and allowed to attach to uncoated (NC), or to ®bronectin (FN, 5 mg/ml)-coated tissue culture plastic surfaces for 60 min at 37°C. TSP2-null
®broblasts showed a defect in adhesion to tissue culture plastic. Coating of tissue culture plates with ®bronectin did not completely correct the attachment
defect. Attached cells were determined by the Cell Titer 96 Assay. The differences are signi®cant (p < 0.005). (B) Coating of tissue culture plastic with TSP2
(5 mg/ml) does not correct the attachment defect in TSP2-null cells. Experiments were performed as described in (A) but attachment was quanti®ed by
colorimetric measurement of cell-adsorbed methylene blue. (C) Rescue of the adhesive defect in TSP2-null dermal ®broblasts by transfection with mTSP2
cDNA. Immortalized dermal ®broblasts derived from TSP2-null mice were transfected with sense and antisense mTSP2 cDNA expression vectors. The
adhesive defect of TSP2-null ®broblasts was corrected by transfection with sense mTSP2 cDNA (S), but not with antisense mTSP2 cDNA (AS).
Experiments were performed as described in (A).
Figure 4.Cytoskeletal morphology of ®broblasts in vitro. Skin
®broblasts from control (left) and TSP2-null (right) mice were plated on
chamber slides for 24 h in the presence of serum. The cytoskeleton was
visualized by staining with phalloidin. Control cells appeared well spread,
with clearly de®ned stress ®bers, whereas mutant cells showed little
spreading and a peripheral deposition of actin. Scale bar: 100 mm.
Figure 5. Zymography of conditioned media from mouse dermal
®broblasts. Serum-free conditioned media from mouse dermal ®broblast
cultures were applied to SDS-PAGE/0.1% gelatin under nonreducing
conditions for zymographic analysis. A 72-kDa gelatinase (MMP2) was
found in the conditioned media of mouse dermal ®broblasts. The
gelatinolytic activity was signi®cantly increased in media from TSP2±/±
®broblasts compared with those from TSP2+/+ cells. Markers of molecular
mass are indicated on the left margin.
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could be shown that a number of tissues, including dermis, adipose
tissue, and thymus, contained a signi®cantly increased density of
small blood vessels (Kyriakides et al, 1998a). Because vascular
density increased with age when embryonic, neonatal, and adult
tissues were compared, it was of interest to determine whether an
increase in vascularization could also be demonstrated in newly
formed tissue in adult animals. For this purpose, polyvinyl alcohol
sponges were inserted subcutaneously in the backs of normal
control and TSP2-null mice and removed 3 weeks later. On gross
examination, sponges from TSP2-null mice were clearly more
vascularized than control sponges, and this impression was
con®rmed by histologic examination, which shows that the
number of blood vessels invading the ®broplastic tissue in the
interstices of the sponge is increased (Fig 6). Similar results were
recently obtained in studies of the foreign body reaction and in
wound healing experiments with TSP2-null mice. Thus, the
vascular density of the foreign body capsule surrounding
subcutaneous silicone rubber implants was six times greater in
mutant than in WT mice (Kyriakides et al, 1999a), and the
vascularity of resorbing granulation tissue in full thickness excisional
skin wounds was also signi®cantly increased in mutant mice
(Kyriakides et al, 1999b).
There are several possible explanations for the angiogenic
phenotype of TSP2-de®cient mice. Dawson et al (1997) have
shown that the type I repeats in TSP1 interact with the CD36
receptor on endothelial cells (EC) and that this interaction is likely
to participate in the antiangiogenic activity of TSP1. In view of the
homology between TSP1 and TSP2, similar interactions might
mediate the antiangiogenic function of TSP2; however, the
functional consequences of activation of the CD36 receptor are
not known, and other cell-surface receptors could be involved. For
example, Gao et al (1996) suggest that the concerted interaction of
TSP1 with integrin avb3 and integrin-associated protein (IAP; CD
47) could modulate endothelial cell properties such as cell
spreading, migration, and chemotaxis, and the binding sites for
these receptors are preserved in TSP2. If a lack of normal TSP2±EC
interactions leads to the development of intrinsically defective EC
in the TSP2-null mouse, as would appear to be the case for
®broblasts, then some property of EC, e.g., adhesion, migration, or
proliferation, should be demonstrably abnormal in culture. We are
currently testing this possibility with EC isolated from TSP2-null
Immortomice. Alternatively, inhibition of EC function by
®broblast-derived TSP2 might be lacking in TSP2-null mice,
resulting in a net shift towards a proangiogenic environment in
TSP2-null tissues.
The ECM, and collagen ®brils in particular, are thought to
provide important morphogenetic cues for the growth of capillaries
by angiogenesis (Polverini, 1996; Sage, 1996). Since there are clear
abnormalities in collagen ®bril structure in TSP2-null mice, the
possibility also exists that abnormal ECM±EC interactions, apart
from direct TSP2±EC interactions, contribute to the increased
vascularity in these mice. Some support for this conjecture is
provided by the observation that vascular density is highest in
tissues in mutant mice in which collagen ®brils appear most
abnormal, i.e., skin and subdermis (Kyriakides et al, 1998a). In
order to test this hypothesis, we plan to implant acellular dermal
matrix strips, obtained from WT and TSP2-null mice, subcut-
aneously into immunode®cient transgenic thrombomodulin-lacZ
mice. Thrombomodulin-lacZ mice have been generated by a
targeted mutation in which a functional lacZ gene was inserted in
one allele at the thrombomodulin locus (Weiler-Guettler et al,
1996). Implants will be removed at different times and the extent of
invasion of blood vessels from the host will be measured, as judged
by the number of b-galactosidase-positive vessels per high power-
®eld in randomly chosen sections from WT and TSP2-null
implants. A higher density of blood vessels in TSP2-null implants
would support the hypothesis that the organization or composition
of dermal matrix from TSP2-null mice provides a stimulus for
angiogenesis.
CONCLUSIONS
Our ®ndings are consistent with the view that matricellular
proteins, such as TSP2, function by modulating cell±matrix
interactions, and thereby cell function. Thus we provide evidence
in this paper that TSP2-null mouse dermal ®broblasts produce
higher than normal levels of MMP2 and that this proteolytic
activity is responsible for the defect in adhesion displayed by these
cells. Although it remains to be proven, increased MMP2 activity
could also account for the abnormal interactions of mouse tendon
®broblasts with adjacent growing collagen ®brils, observed in
developing tendon, and the abnormally shaped collagen ®brils seen
in mature mouse skin and tendon. Whereas the increased
angiogenesis detected in some tissues in the TSP2-null mouse is
consistent with the antiangiogenic activity of TSP2 in vitro, the
molecular and cellular basis for this activity is less certain.
Possibilities include the ability of TSP2 to bind and sequester
angiogenic factors such as bFGF or VEGF, changes in cell signaling
that result from the failure of TSP2 to interact with its several cell-
surface receptors, and more complex mechanisms that implicate an
abnormal extracellular matrix in increased angiogenesis.
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